Cargando…

A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis

Left ventricular hypertrophy is a risk factor for cardiovascular mortality in patients on peritoneal dialysis (PD). Because icodextrin has a greater ultrafiltration power compared with glucose-based solutions for long dwell, it could improve left ventricular mass by reducing fluid overload. This was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordeiro, Lilian, Ishikawa, Walther Yoshiharu, Andreoli, Maria Claudia C., Canziani, Maria Eugenia F., Araujo, Luiza Karla R. P., Pereira, Benedito J., Abensur, Hugo, Moysés, Rosa M. A., Elias, Rosilene M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500040/ https://www.ncbi.nlm.nih.gov/pubmed/36138087 http://dx.doi.org/10.1038/s41598-022-20157-z

Ejemplares similares

A feasibility study of avoiding positive calcium balance and parathyroid hormone increase in patients on peritoneal dialysis
por: Piraciaba, Maria Clara Teixeira, et al.
Publicado: (2022)

Clinical effects of icodextrin in peritoneal dialysis
por: Cnossen, Trijntje T., et al.
Publicado: (2008)

Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis
por: Stachowska-Pietka, Joanna, et al.
Publicado: (2023)

Sex Modulates Cardiovascular Effects of Icodextrin-Based Peritoneal Dialysis Solutions
por: Paniagua, Ramón, et al.
Publicado: (2022)

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
por: Johnson, David Wayne, et al.
Publicado: (2001)

Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
por: Dousdampanis, Periklis, et al.
Publicado: (2013)

Biphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis
por: Huang, Yan-Feng, et al.
Publicado: (2015)

The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis
por: Becker, Monika, et al.
Publicado: (2019)

Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport
por: Olszowska, Anna, et al.
Publicado: (2019)

A comparative study of the effect of icodextrin based peritoneal dialysis and hemodialysis on lipid metabolism
por: Kadiroğlu, A. K., et al.
Publicado: (2013)

Icodextrin and spurious hyperglycemia in peritoneal dialysis patients: a hospital-wide attempt to prevent such errors
por: Asakura, Yusuke, et al.
Publicado: (2017)

A Novel Diagnostic Approach for Suspected Icodextrin Pleural Effusion in a Peritoneal Dialysis Patient
por: Onuigbo, Macaulay Amechi Chukwukadibia, et al.
Publicado: (2019)

Moderate hyperosmolar hyponatremia caused by excessive off-label use of icodextrin during peritoneal dialysis
por: Chaudhari, Harshad, et al.
Publicado: (2023)

Icodextrin Improves the Serum Potassium Profile with the Enhancement of Nutritional Status in Continuous Ambulatory Peritoneal Dialysis Patients
por: Yi, Joo-Hark, et al.
Publicado: (2009)

Use of Toll-like receptor assays for the detection of bacterial contaminations in icodextrin batches released for peritoneal dialysis
por: Hacine-Gherbi, Hêla, et al.
Publicado: (2017)

Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study
por: Chang, Tae Ik, et al.
Publicado: (2016)

Protective measures against ultrafiltration failure in peritoneal dialysis patients
por: Aguirre, Anna Rita, et al.
Publicado: (2011)

Bone Mineral Parameters in Peritoneal Dialysis Patients after Lowering Calcium Concentration in Dialysis Fluids: A Case Series in Patients Using Icodextrin
por: Verschuur, Lara C., et al.
Publicado: (2023)

Influence of 4% icodextrin solution on peritoneal tissue response and adhesion formation
por: Klink, Christian D, et al.
Publicado: (2013)

Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study
por: Vychytil, Andreas, et al.
Publicado: (2008)

Longitudinal analysis of cardiac structure and function in incident-automated peritoneal dialysis: comparison between icodextrin solution and glucose-based solution
por: Chen, Jin-Bor, et al.
Publicado: (2018)

A Case of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient Receiving Peritoneal Dialysis With Icodextrin Exposure
por: Alotaibi, Manal E, et al.
Publicado: (2022)

Clinical outcomes of incident peritoneal dialysis patients coming from kidney transplantation program: A case-control study
por: da Costa, Laurisson Albuquerque, et al.
Publicado: (2020)

Icodextrin-associated hepatotoxicity
por: Gungor, Ozkan, et al.
Publicado: (2011)

Ankle-Brachial Index: A Simple Way to Predict Mortality among Patients on Hemodialysis - A Prospective Study
por: Jimenez, Zaida Noemy Cabrera, et al.
Publicado: (2012)

Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K(+) load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients
por: Yi, Joo-Hark, et al.
Publicado: (2009)

Peritoneal dialysis: why not?
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2023)

Icodextrin and skin rash: Unusual presentation
por: Ankur, G., et al.
Publicado: (2012)

A Case Report on Allergic Rash Caused by Icodextrin
por: Cevher, Şimal Köksal, et al.
Publicado: (2014)

Benefits of a Continuous Ambulatory Peritoneal Dialysis (CAPD) Technique with One Icodextrin-Containing and Two Biocompatible Glucose-Containing Dialysates for Preservation of Residual Renal Function and Biocompatibility in Incident CAPD Patients
por: Yoon, Hye Eun, et al.
Publicado: (2014)

What could be the expected solute clearance with single exchange of icodextrin?
por: Jeloka, T. K., et al.
Publicado: (2014)

Icodextrin reduces adhesion formation following gynecological surgery in rabbits
por: Khani, Behnaz, et al.
Publicado: (2011)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Dialysis-related thrombocytopenia: a case report
por: Duayer, Irene Faria, et al.
Publicado: (2021)

Prevention of Intraabdominal Adhesions: An Experimental Study Using Mitomycin-C and 4% Icodextrin
por: Urkan, Murat, et al.
Publicado: (2017)

Effects of Icodextrin Solution (Adept(®)) on Ovarian Cancer Cell Proliferation in an In Vitro Model
por: Chen, Wen-Hsin, et al.
Publicado: (2022)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_230jla65huqd3j8fajh2976c2h